A Study to Evaluate the Relationship Between Cetuximab Therapy and Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2015
At a glance
- Drugs Cetuximab (Primary)
- Indications Solid tumours
- Focus Pharmacodynamics
- Sponsors Bristol-Myers Squibb
- 05 Feb 2010 Actual end date (Dec 2009) and actual number of patients (3) added as reported by ClinicalTrials.gov.
- 05 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.